Price Alert

Eupraxia Pharmaceuticals ... (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

5.32

0.04 (0.76%)

At close: Aug 15, 2025, 3:49 PM

5.30

-0.43%

After-hours: Aug 15, 2025, 04:55 PM EDT

Eupraxia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	27.45M	33.1M	8.66M	23.32M	48.59M	19.34M	33.21M	19.1M	18.85M	24.74M	11.8M	17.39M	16.88M	20.89M	33.67M	36.08M	31.12M
Short-Term Investments	n/a	n/a	n/a	8.59M	n/a	n/a	n/a	n/a	n/a	n/a	18.17M	18.06M	9.02M	9.01M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	80.23K	80.76K	18.43K	4.6K	7.54K	6.9K	4.21K	5.84K	2.84K	3.37K	672.00	854.00	1.03K	31.37K	60.3K	n/a	n/a
Receivables	238.53K	228.87K	105.93K	155.24K	167.24K	190.61K	67.84K	16.46K	117.95K	n/a	285.62K	376.62K	350.15K	337.03K	n/a	n/a	479.09K
Inventory	n/a	n/a	n/a	n/a	2.00	-340.53K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	143.25K	212.39K	n/a	n/a	n/a	52.02K	250.4K	n/a	417.25K	186.82K	n/a	270.99K	n/a	n/a	187.33K
Total Current Assets	28.61M	34.44M	9.89M	33.56M	49.01M	19.8M	33.77M	19.73M	19.22M	25.18M	30.78M	36.4M	26.64M	30.6M	34.24M	36.86M	32.26M
Property-Plant & Equipment	546.54K	424.92K	456.49K	609.57K	561.4K	456.25K	573.77K	610.92K	657.57K	695.48K	665.38K	664.5K	556.48K	589.07K	612.41K	279.92K	298.9K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	626.77K	505.68K	474.92K	615.93K	568.94K	463.15K	577.98K	616.77K	660.41K	698.85K	666.06K	665.36K	557.51K	620.44K	672.71K	279.92K	298.9K
Total Assets	29.23M	34.94M	10.36M	34.17M	49.58M	20.27M	34.35M	20.35M	19.88M	25.88M	31.45M	37.06M	27.2M	31.22M	34.91M	37.14M	32.56M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	4.55M	12.93M	10.4M	15.33M	11M	179.47K	79.42K	78.42K	163.41K	76.03K	74.44K	73.68K	n/a	6.12M
Other Current Liabilities	n/a	1.49M	30.18K	4.27M	3.68M	858.63K	1.04M	3.25M	2M	1.6M	1.85M	3.35M	1.06M	1.4M	2.71M	710.77K	320.14K
Total Current Liabilities	2.2M	3.1M	2.37M	15.88M	25.07M	19.37M	19.28M	14.6M	2.18M	4.14M	2.25M	3.59M	1.26M	2.27M	2.85M	816.35K	7.66M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	28.08K	10.59M	11.99M	10.12M	9.76M	9.62M	9.84M	9.08M	8.78M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.67M	-86.55K	n/a	-96.67K	-542.97K	32.05K	-168.72K	38.17K
Total Long-Term Liabilities	n/a	n/a	14.3K	34.95K	n/a	n/a	11.79K	59.1K	10.64M	10.37M	10.12M	9.86M	9.62M	9.4M	9.23M	8.78M	183.69K
Total Liabilities	2.2M	3.1M	2.39M	15.92M	25.07M	19.37M	19.29M	14.66M	12.82M	14.51M	12.37M	13.45M	10.88M	11.67M	12.07M	9.6M	7.84M
Total Debt	52.77K	71.86K	93.05K	4.66M	12.93M	10.45M	15.41M	11.13M	10.82M	10.55M	10.29M	10.02M	9.77M	9.56M	9.38M	8.84M	6.36M
Common Stock	116.84M	116.36M	116.32M	159.15M	157.41M	92.91M	118.05M	99.37M	92.69M	92.34M	91.87M	91.87M	80.71M	80.71M	80.76M	80.76M	74.15M
Retained Earnings	-137.77M	-131M	-123.49M	-117.55M	-150.95M	-108.21M	-122.7M	-110.23M	-102.41M	-97.45M	-88.62M	-83.97M	-77.88M	-74.19M	-70.47M	-65.49M	-60.06M
Comprehensive Income	-4.12M	-4.16M	-2.79M	-2.92M	-3.71M	-2.71M	n/a	1.32	-1.35	-2.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	28.6M	33.4M	9.52M	14.83M	26.45M	2.22M	17.04M	7.44M	8.63M	12.86M	20.31M	24.7M	17.22M	20.39M	23.61M	28.16M	25.17M
Total Investments	n/a	n/a	n/a	8.59M	n/a	n/a	n/a	n/a	n/a	n/a	18.17M	18.06M	9.02M	9.01M	n/a	n/a	n/a